The positive results obtained with this novel process at our facility lay the foundations for investing resources and personnel in the more accurate management of DM in hospitals, performed by specialized diabetes teams, encouraging the use of appropriate technologies (e.g., real-time continuous glucose monitoring (CGM) and insulin pump) with the aim of reducing postoperative infectious complications. This evidence concerns the gene INS and diabetes mellitus.